Abstract
IntroductionRefractory ascites (RA) in end stage liver disease (ESLD) confers a poor prognosis in non-liver transplant (LT) candidates; therefore heralds a palliative stage of management. Standard care in RA is...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
